Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Patient-Based Real-Time Quality Control: Review and Recommendations.

Badrick T, Bietenbeck A, Cervinski MA, Katayev A, van Rossum HH, Loh TP; International Federation of Clinical Chemistry, and Laboratory Medicine Committee on Analytical Quality.

Clin Chem. 2019 Jul 1. pii: clinchem.2019.305482. doi: 10.1373/clinchem.2019.305482. [Epub ahead of print]

PMID:
31263035
2.

LC-MS/MS assay for the quantification of testosterone, dihydrotestosterone, androstenedione, cortisol and prednisone in plasma from castrated prostate cancer patients treated with abiraterone acetate or enzalutamide.

van Nuland M, Venekamp N, Wouters WME, van Rossum HH, Rosing H, Beijnen JH.

J Pharm Biomed Anal. 2019 Jun 5;170:161-168. doi: 10.1016/j.jpba.2019.03.043. Epub 2019 Mar 20.

PMID:
30925273
3.

Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds.

van Rossum HH, van den Broek D.

Clin Chem Lab Med. 2019 Mar 23. pii: /j/cclm.ahead-of-print/cclm-2019-0027/cclm-2019-0027.xml. doi: 10.1515/cclm-2019-0027. [Epub ahead of print]

PMID:
30903753
4.

Moving average quality control: principles, practical application and future perspectives.

van Rossum HH.

Clin Chem Lab Med. 2019 May 27;57(6):773-782. doi: 10.1515/cclm-2018-0795. Review.

5.

Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot.

Moritz R, Muller M, Korse CM, van den Broek D, Baas P, van den Noort V, Ten Hoeve JJ, van den Heuvel MM, van Rossum HH.

Clin Chim Acta. 2018 Dec;487:6-14. doi: 10.1016/j.cca.2018.09.015. Epub 2018 Sep 8.

PMID:
30201371
6.

Serum Testosterone by Liquid Chromatography Tandem Mass Spectrometry for Routine Clinical Diagnostics.

van Winden LJ, van Tellingen O, van Rossum HH.

Methods Mol Biol. 2018;1730:93-102. doi: 10.1007/978-1-4939-7592-1_7.

PMID:
29363068
7.

A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patients.

Korse CM, Buning-Kager JCGM, Linders TC, Heijboer AC, van den Broek D, Tesselaar MET, van Tellingen O, van Rossum HH.

Clin Chim Acta. 2017 Jun;469:130-135. doi: 10.1016/j.cca.2017.04.001. Epub 2017 Apr 4.

PMID:
28385629
8.

Moving Average for Continuous Quality Control: Time to Move to Implementation in Daily Practice?

van Rossum HH, Kemperman H.

Clin Chem. 2017 May;63(5):1041-1043. doi: 10.1373/clinchem.2016.269258. Epub 2017 Mar 20. No abstract available.

9.

Optimization and validation of moving average quality control procedures using bias detection curves and moving average validation charts.

van Rossum HH, Kemperman H.

Clin Chem Lab Med. 2017 Feb 1;55(2):218-224. doi: 10.1515/cclm-2016-0270.

PMID:
27522620
10.

A method for optimization and validation of moving average as continuous analytical quality control instrument demonstrated for creatinine.

van Rossum HH, Kemperman H.

Clin Chim Acta. 2016 Jun 1;457:1-7. doi: 10.1016/j.cca.2016.03.008. Epub 2016 Mar 22.

PMID:
27012515
11.

Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn.

van Rossum HH, de Kraa N, Thomas M, Holleboom CAG, Castel A, van Rossum AP.

Pract Lab Med. 2015 Oct 22;3:17-22. doi: 10.1016/j.plabm.2015.10.001. eCollection 2015 Dec 1.

12.

The one hour lactose tolerance test.

van Rossum HH, van Rossum AP, van Geenen EJ, Castel A.

Clin Chem Lab Med. 2013 Sep;51(9):e201-3. doi: 10.1515/cclm-2013-0111. No abstract available.

PMID:
23612673
13.

Serum testosterone quantitation by liquid chromatography-tandem mass spectrometry: interference from blood collection tubes.

Shi RZ, van Rossum HH, Bowen RA.

Clin Biochem. 2012 Dec;45(18):1706-9. doi: 10.1016/j.clinbiochem.2012.08.008. Epub 2012 Aug 16.

PMID:
22971570
14.

Point: A call for advanced pharmacokinetic and pharmacodynamic monitoring to guide calcineurin inhibitor dosing in renal transplant recipients.

van Rossum HH, Press RR, den Hartigh J, de Fijter JW.

Clin Chem. 2010 May;56(5):732-5. doi: 10.1373/clinchem.2009.141135. Epub 2010 Mar 5. No abstract available.

15.

Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives.

van Rossum HH, de Fijter JW, van Pelt J.

Ther Drug Monit. 2010 Feb;32(1):3-10. doi: 10.1097/FTD.0b013e3181c0eecb. Review.

PMID:
20009796
16.

Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12.

van Rossum HH, Romijn FP, Smit NP, de Fijter JW, van Pelt J.

Biochem Pharmacol. 2009 Apr 1;77(7):1206-12. doi: 10.1016/j.bcp.2008.12.009. Epub 2008 Dec 30.

PMID:
19154728
17.

Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies.

van Rossum HH, Romijn FP, Sellar KJ, Smit NP, van der Boog PJ, de Fijter JW, van Pelt J.

Clin Chem. 2008 Mar;54(3):517-24. doi: 10.1373/clinchem.2007.097253. Epub 2008 Jan 24.

18.

Calcineurin activity and inhibition in skin and (epi)dermal cell cultures.

Smit NP, Van Rossum HH, Romijn FP, Sellar KJ, Breetveld M, Gibbs S, Van Pelt J.

J Invest Dermatol. 2008 Jul;128(7):1686-90. doi: 10.1038/sj.jid.5701244. Epub 2008 Jan 17.

19.

Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood.

Sellar KJ, van Rossum HH, Romijn FP, Smit NP, de Fijter JW, van Pelt J.

Anal Biochem. 2006 Nov 1;358(1):104-10. Epub 2006 Aug 24.

PMID:
16979577

Supplemental Content

Loading ...
Support Center